0000899243-22-017091.txt : 20220506 0000899243-22-017091.hdr.sgml : 20220506 20220506161515 ACCESSION NUMBER: 0000899243-22-017091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220504 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yu Debra CENTRAL INDEX KEY: 0001869480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40947 FILM NUMBER: 22901230 MAIL ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS STREET 2: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LianBio CENTRAL INDEX KEY: 0001831283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 486-2308 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-04 0 0001831283 LianBio LIAN 0001869480 Yu Debra C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 0 1 0 0 See Remarks Ordinary Shares 2022-05-04 4 M 0 1000000 1.71 A 1000000 D Stock Option (Right to Buy) 1.71 2022-05-04 4 M 0 1000000 0.00 D 2030-01-01 Ordinary Shares 1000000 999947 D 1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date. President & Chief Strategy Officer By: /s/ Angela Chen, Attorney-in-Fact 2022-05-06